These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23361566)

  • 1. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?
    Falcone M; Russo A; Cassetta MI; Lappa A; Tritapepe L; d'Ettorre G; Fallani S; Novelli A; Venditti M
    J Infect Chemother; 2013 Aug; 19(4):732-9. PubMed ID: 23361566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of daptomycin in critically ill patients.
    Soraluce A; Asín-Prieto E; Rodríguez-Gascón A; Barrasa H; Maynar J; Carcelero E; Soy D; Isla A
    Int J Antimicrob Agents; 2018 Aug; 52(2):158-165. PubMed ID: 29572042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure].
    Sarriá Cepeda C
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections.
    Di Paolo A; Tascini C; Polillo M; Gemignani G; Nielsen EI; Bocci G; Karlsson MO; Menichetti F; Danesi R
    Int J Antimicrob Agents; 2013 Sep; 42(3):250-5. PubMed ID: 23891432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of daptomycin in a clinical setting.
    Tsukada H; Tsuji Y; Yamashina T; Tsuruta M; Hiraki Y; Tsuruyama M; Ogami C; Kawasuji H; Sakamaki I; Yamamoto Y
    J Infect Chemother; 2020 Feb; 26(2):230-235. PubMed ID: 31735632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.
    Abdel-Rahman SM; Chandorkar G; Akins RL; Bradley JS; Jacobs RF; Donovan J; Benziger DP
    Pediatr Infect Dis J; 2011 Aug; 30(8):712-4. PubMed ID: 21317681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy.
    De Gregori S; De Silvestri A; Molinaro MD; Monzillo V; Biscarini S; Colaneri M; Gallazzi I; Bartoli A; Bruno R; Seminari E
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):547-554. PubMed ID: 34231117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.
    Avery LM; Kuti JL; Weisser M; Egli A; Rybak MJ; Zasowski EJ; Arias CA; Contreras GA; Chong PP; Aitken SL; DiPippo AJ; Wang JT; Britt NS; Nicolau DP
    Int J Antimicrob Agents; 2019 Sep; 54(3):346-350. PubMed ID: 31284042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.
    Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin serum levels in critical patients undergoing continuous renal replacement.
    Falcone M; Russo A; Cassetta MI; Lappa A; Tritapepe L; Fallani S; Vullo V; Venditti M; Novelli A
    J Chemother; 2012 Oct; 24(5):253-6. PubMed ID: 23182044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin use in a neonate: serum level monitoring and outcome.
    Sarafidis K; Iosifidis E; Gikas E; Tsivitanidou M; Drossou-Agakidou V; Roilides E
    Am J Perinatol; 2010 May; 27(5):421-4. PubMed ID: 20013573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
    Cojutti PG; Candoni A; Ramos-Martin V; Lazzarotto D; Zannier ME; Fanin R; Hope W; Pea F
    J Antimicrob Chemother; 2017 Aug; 72(8):2342-2350. PubMed ID: 28575511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.
    Louie A; Kaw P; Liu W; Jumbe N; Miller MH; Drusano GL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):845-51. PubMed ID: 11181370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease.
    Samura M; Takada K; Yamamoto R; Ito H; Nagumo F; Uchida M; Kurata T; Koshioka S; Enoki Y; Taguchi K; Higashita R; Kunika N; Tanikawa K; Matsumoto K
    Pharm Res; 2021 Jun; 38(6):1041-1055. PubMed ID: 34013390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation.
    Zhang LC; Li QY; Zhang YQ; Shan TC; Li Y; Li YH; Han H; Qin WD; Guo HP; Zhao W; Tang BH; Chen XM
    J Antimicrob Chemother; 2024 Jul; 79(7):1697-1705. PubMed ID: 38814793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections.
    Goutelle S; Roux S; Gagnieu MC; Valour F; Lustig S; Ader F; Laurent F; Chidiac C; Ferry T
    Antimicrob Agents Chemother; 2016 May; 60(5):3148-51. PubMed ID: 26902764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin in paediatrics: current knowledge and the need for future research.
    Principi N; Caironi M; Venturini F; Pani L; Esposito S
    J Antimicrob Chemother; 2015 Mar; 70(3):643-8. PubMed ID: 25406298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
    Abdel-Rahman SM; Benziger DP; Jacobs RF; Jafri HS; Hong EF; Kearns GL
    Pediatr Infect Dis J; 2008 Apr; 27(4):330-4. PubMed ID: 18316988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.
    Vilay AM; Grio M; Depestel DD; Sowinski KM; Gao L; Heung M; Salama NN; Mueller BA
    Crit Care Med; 2011 Jan; 39(1):19-25. PubMed ID: 20890189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.